oPtic Nerve Sheath Evaluation in gianT Cell aRtheritis by UltraSound
ConditionGiant Cell Arteritis (GCA)
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50+
SponsorHôpital NOVO
About this trial
The purpose of this study is to evaluate whether the measure of the optic nerve sheath is a reliable diagnostic marker for giant cell arteritis
Eligibility criteria
Qualifiers
Patient with suspected GCA
Patient over 50 years
Disqualifiers
Patient with history of GCA
Patient with a history of polymyalgia rheumatic (PMR) without initial PET scan
Patient with a history of retinal disease, demyelinating disease, or intracranial hypertension
Use of corticosteroids > 0.5mg/kg in the last 2 weeks
Trial design
Treatments tested in this trial
- orbital ultrasound
Treatment groups
190 Participants
are divided into 1 treatment groupLocations
9Rhumatology departement - Centre Hospitalier Aix en Provence Aix-en-Provence France
Rhumatology department - Centre Hospitalier Universitaire de Brest Brest France
Internal Medecine Department- CHU Caen Caen France
Internal Medicine and Clinical Immulogy department - Centre Hospitalier Universitaire de Dijon Dijon France
Sponsors and collaborators
Hôpital NOVO
Lead sponsor
Source ClinicalTrials.gov